SCHEMBL1122643

SCHEMBL1122643

O=C(O)C(Cl)S(=O)(=O)Nc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
ALDH1A1 P00352 4/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
MAPT P10636 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
IL1RN P18510 1/20 0.44
ERAP1 Q9NZ08 1/20 0.44
PKM P14618 1/20 0.41
CA12 O43570 2/20 0.41
CA9 Q16790 2/20 0.41
GAA P10253 3/20 0.41
ATM Q13315 2/20 0.41
LMNA P02545 1/20 0.41
GFER P55789 1/20 0.41
HSP90AA1 P07900 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21283390 0.78 KEAP1 (0.47) KEAP1CA1CA2ALDH1A1KMT2A
SCHEMBL7264824 0.73 KEAP1 (0.46) KEAP1CA1CA2ALDH1A1KMT2A
SCHEMBL8899869 0.73 GAA (0.44) KEAP1CA1CA2ALDH1A1KMT2A
SCHEMBL187277 0.71 KEAP1 (0.52) KEAP1CA1CA2ALDH1A1KMT2A
SCHEMBL4099446 0.71 KEAP1 (0.58) KEAP1CA1CA2ALDH1A1KMT2A
SCHEMBL6332337 0.70 MMP2 (0.44) KEAP1CA1CA2ALDH1A1KMT2A
SCHEMBL10499595 0.70 KEAP1 (0.42) KEAP1CA1CA2ALDH1A1KMT2A
SCHEMBL15462548 0.70 KEAP1 (0.47) KEAP1CA1CA2ALDH1A1KMT2A
SCHEMBL27916184 0.69 SMN1; SMN2 (0.44) CA1CA2ALDH1A1MAPTSMN1; SMN2
SCHEMBL8658263 0.69 EPHX1 (0.46) CA1CA2ALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379508-B9 N-(ARYL)-2-ARYLETHENESULFONAMIDES AND THERAPEUTIC USES THEREOF UNIV TEMPLE (US) 2011-02-09 EP disclosed
EP-1379508-B1 N-(ARYL)-2-ARYLETHENESULFONAMIDES AND THERAPEUTIC USES THEREOF UNIV TEMPLE (US) 2010-09-01 EP disclosed
US-6646009-B2 Use against proliferative disorders including cancer, and as a radioprotective compound for normal cells from ionizing radiation Temple University — Of Commonwealth System of Higher Education 2003-11-11 US disclosed